Search results
Patients file lawsuits in Charlotte court alleging issues caused by Merck’s HPV vaccines
Charlotte Observer via Yahoo News· 3 months agoA vaccine manufactured in North Carolina — and the only one given to protect against human...
HPV linked to higher risk of heart disease, stroke
United Press International via Yahoo News· 4 months agoWomen are four times more likely to die from heart disease and six times more likely to die from stroke if infected with a high-risk strain of human...
What Are Flat Warts?
Verywell Health via Yahoo News· 1 year agoFlat warts (or plane warts) are caused by viruses, but they are usually harmless. Warts are small, slightly raised skin growths caused by the human...
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks via Yahoo Finance· 1 month agoMerck MRK reported adjusted earnings of $2.07 per share for first-quarter 2024, beating the Zacks...
Merck (MRK) Beats on Q1 Earnings and Sales, Ups 2023 View
Zacks via Yahoo Finance· 1 year agoMerck MRK reported first-quarter 2023 adjusted earnings of $1.40 per share, which beat the Zacks...
Merck (MRK) Q4 Earnings Beat, Sales Miss, Upbeat '24 View
Zacks via Yahoo Finance· 4 months agoMerck MRK reported adjusted earnings of 3 cents per share in fourth-quarter 2023, wider than the...
Merck (MRK) to Report Q2 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 10 months agoMerck MRK will report second-quarter 2023 results on Aug 1, before market open. In the last reported...
Adults need shots, too: Find out which vaccines are important for heart health
NewMediaWire via Yahoo Finance· 2 years agoDALLAS, Sept. 13, 2022 — While most parents are good at keeping track of vaccines kids need to stay...
Merck (MRK) Beats on Q4 Earnings & Sales, 2023 View Disappoints
Zacks via Yahoo Finance· 1 year agoMerck MRK reported fourth-quarter 2022 adjusted earnings of $1.62 per share, which beat the Zacks...
Merck (MRK) Q2 Earnings & Revenues Top, COVID Drug Helps Sales
Zacks via Yahoo Finance· 2 years agoMerck (MRK) beats on Q2 estimates for earnings and sales. The company continues to see robust growth...
